Lysine: Clinical Trials

4 trials of Lysine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Recruiting 1, Unknown 1
Phase 21Recruiting 1

Follow Lysine: new trials by email Literature Review of Lysine trials Research Report on Lysine

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
Actinium Ac 225 DOTATATE RYZ101, Biospecimen Collection, Computed Tomography - Recurrent Meningioma
Phase 1 / Phase 2RecruitingJoshua Palmer302025-11-122026-08-13
Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3
L-Lysine, Normal Saline - Diabetes Mellitus, Type 2
Phase 1CompletedVanderbilt University Medical Center232022-03-092024-06-05
Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
177Lu-DOTA-EB-TATE 1, 177Lu-DOTA-TATE, 177Lu-DOTA-EB-TATE 2 - Neuroendocrine Tumors
Phase 1UnknownPeking Union Medical College Hospital602017-04-302022-08-31
The Effect of Acute Lysine Administration on α-aminoadipic Acid
L-Lysine, Normal (0.9%) Saline - Healthy, Pre-diabetic
Phase 1CompletedVanderbilt University132016-05-012017-02-07

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Glucose Intolerance (1)  ·  Meningioma (1)  ·  Neuroendocrine Tumors (1)

Sponsors

Joshua Palmer (1)  ·  Peking Union Medical College Hospital (1)  ·  Vanderbilt University (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (2)  ·  China (1)

Top investigators

Jane F Ferguson, PhD (1)  ·  Jane Ferguson, PhD (1)  ·  Joshua D Palmer, MD (1)  ·  Zhaohui Zhu, M.D.,PhD (1)

Results publications

PMID 31832728, PMID 37075254